Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open Labeled Phase 2 Study of Gemcitabine in Combination With Cisplatin, 5-FU (24h CI) and Folinic Acid in Patients With Inoperable Esophageal Cancer

NCT00759226 is registered in ClinicalTrials.gov with CONKO-Studiengruppe as lead sponsor.

NCT NCT00759226
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00759226 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open Labeled Phase 2 Study of Gemcitabine in Combination With Cisplatin, 5-FU (24h CI) and Folinic Acid in Patients With Inoperable Esophageal Cancer
Lead sponsor
CONKO-Studiengruppe
Phase
Phase 2
Overall status
Completed
Start date
July 31, 2002
Completion date
August 31, 2007
Enrollment
92 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

esophageal cancer